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Nanotechnology and the production of nanomaterials have been expanding rapidly in recent 
years. Since many types of engineered nanoparticles are suspected to be toxic to living 
organisms and to have a negative impact on the environment, the process of designing new 
nanoparticles and their applications must be accompanied by a thorough exposure risk 
analysis. (Quantitative) Structure-Activity Relationship ([Q]SAR) modelling creates 
promising options among the available methods for the risk assessment. These in silico 
models can be used to predict a variety of properties, including the toxicity of newly designed 
nanoparticles. However, (Q)SAR models must be appropriately validated to ensure the clarity, 
consistency and reliability of predictions. This paper is a joint initiative from recently 
completed European research projects focused on developing (Q)SAR methodology for 
nanomaterials. The aim was to interpret and expand the guidance for the well-known ÒOECD 
Principles for the Validation, for Regulatory Purposes, of (Q)SAR ModelsÓ, with reference to 
nano-(Q)SAR, and present our opinions on the criteria to be fulfilled for models developed 
for nanoparticles. 
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1. Introduction 
 
Nanotechnology and the production of nanomaterials have been expanding rapidly in 
recent years. For definitions of nanotechnology, nanomaterials and nanoparticles, readers are 
directed to the following references: (Lvestam et al., 2010; Rauscher et al., 2013). Since 
many types of engineered nanoparticles are suspected to be toxic to living organisms and to 
have a negative impact on the environment, the process of designing new and safe 
nanoparticles must be accompanied by a thorough risk analysis (Hassellov et al., 2008; Silva 
et al., 2015). 
Computational techniques, especially (Quantitative) Structure-Activity Relationship 
([Q]SAR) modelling, provide hazard estimates which are fundamental for risk assessment. 
The concept underpinning (Q)SAR (Cherkasov et al., 2014; Dearden, 2016) is that, when the 
structural characteristics (called ÒdescriptorsÓ) are known for a group of compounds, and the 
experimental activity data are available only for a few of them, it is possible to predict the 
unknown activities for the remaining compounds directly from the descriptors and a suitable 
mathematical model derived from algorithmic analysis of the available data. Developed 
models can be either qualitative (SAR) or quantitative (QSAR) in nature. (It should be noted 
that variations on these definitions are found in the [Q]SAR literature.) A similar approach 
can be employed to predict various physicochemical properties; such models are commonly 
known as Quantitative Structure-Property Relationships (QSPRs). Although the development 
and validation of computational models are both impossible without utilising high-quality 
experimental data, the application of (Q)SAR/QSPR may help to significantly reduce the time, 
cost, and the number of required laboratory tests (Gajewicz et al., 2012; Puzyn et al., 2009; 
Tantra et al., 2015). 
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Since the terms (Q)SAR/QSPR have traditionally referred to the modelling of the 
molecular structures of organic compounds, as opposed to nanoparticles, the abbreviation 
Ònano-(Q)SARÓ is often used to highlight the specificity of such models to nano-structures 
(Gajewicz et al., 2012; Puzyn et al., 2009). Alternatively, the terms Quantitative 
Nanostructure-Activity Relationships (QNAR) (Fourches et al., 2010), Quantitative 
Nanostructure-Toxicity Relationships (QNTR) (Le et al., 2013) and nano-SAR (Liu et al., 
2013b) are also used in the literature. 
In order to address the opportunities offered by modelling the toxicity and properties 
of nanoparticles, the European Commission funded five modelling projects: MODERN 
(Brehm et al., 2017), Mod-Enp-Tox (Vriens et al., 2017), PreNanoTox, MembraneNanoPart 
(Lopez et al., 2017) and NanoPUZZLES (Richarz et al., 2017) from 2013-2015 and a further 
project to assist in the management of data: eNanoMapper (Jeliazkova et al., 2015), from 
2014 Ð 2017, within the EU NanoSafety Cluster (https://www.nanosafetycluster.eu/). Herein, 
these projects are collectively referred to as the NanoSafety Modelling Cluster, originally 
comprising the five projects and later joined by eNanoMapper. The projects within the 
NanoSafety Modelling Cluster concentrated expertise in the development of (Q)SAR models 
and other chemoinformatic techniques for nanoparticles. This expertise confirms that nano-
QSARs/QNARs/QNTRs can be successfully used to predict the physicochemical properties 
and bioactivity of nanoparticles as well as to assist in the identification of possible 
mechanisms of toxicity at different levels of biological organisation. For example, the toxicity 
of metal oxides to the bacterium Escherichia coli (a prokaryotic system) was shown to be 
related to the release of metal cations from the nanoparticle surface, whereas their toxicity to 
human keratinocyte cells (an eukaryotic system) is mainly related to the redox properties of 
the surface of the nanoparticle, thus providing an insight into different mechanisms of action 
(Gajewicz et al., 2015). 
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  The Organisation for Economic Cooperation and Development (OECD) published a 
set of principles in 2004 (OECD, 2004) for the validation of QSAR models, along with 
detailed guidance in 2007 describing the application of the so-called ÒOECD Principles for 
the Validation, for Regulatory Purposes, of (Q)SAR ModelsÓ (OECD, 2007). The Guidance 
proposes that five criteria, commonly referred to as Òthe OECD Principles for ValidationÓ, 
should be considered to evaluate a QSAR: (1) a clear definition of the endpoint; (2) the use of 
an unambiguous algorithm; (3) the necessity of defining the applicability domain; (4) 
calculating appropriate measures of goodness-of-fit, robustness and predictive ability; and (5), 
whenever possible, providing a mechanistic interpretation. The appropriate validation of 
(Q)SARs, according to these principles, is crucial to demonstrate their true predictive ability 
and limitations in a regulatory context. Whilst these principles may be considered generally 
applicable to all (Q)SARs, including nano-QSARs, the fact that the development of the 
original principles, and their accompanying guidance from the OECD, was based on 
consideration of QSARs for small organic molecules means there is a need to consider 
whether the guidance associated with their application requires revision and/or addition to be 
appropriately applied to the evaluation of nano-QSARs. Some of the considerations which are 
specific to, or otherwise typical for, nano-QSAR studies that prompt us to ask this question 
are as follows: (1) the challenge of representing nanomaterial structures, which affects which 
information should be provided to allow nanomaterial descriptor values to be reproduced (c.f. 
principle 2); (2) nanomaterial-specific data quality considerations (c.f. principle 1); (3) the 
typically small size of nano-QSAR datasets (c.f. principle 4). We discuss these issues in detail, 
along with appropriate literature references, in the next section of our article. This paper is a 
joint initiative of five of the EU research projects (MODERN, PreNanoTox, 
MembraneNanoPart, NanoPUZZLES and eNanoMapper), which focused on developing 
(Q)SAR methodology, and supporting resources, for nanomaterials. The aim of the paper is to 
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reconsider some of the most important aspects of the evaluation process from the perspective 
of nano-(Q)SAR models in the context of the existing OECD Principles for Validation. 
However, whilst they are discussed from a nano-(Q)SAR perspective, it should be noted that 
various suggestions made herein, as will be indicated in the text, are also applicable to QSAR 
modelling of conventional (small molecule) chemicals.  
Here it should be noted that the aim of this paper is not to be a comprehensive review of 
nano-(Q)SAR models. A variety of recommended reviews of nano-(Q)SAR models have been 
published in recent years (Burello, 2017; Chen et al., 2017; Oksel et al., 2015a; Oksel et al., 
2017; Oksel et al., 2015b; Tantra et al., 2015; Winkler, 2016; Worth et al., 2017). Some 
articles discuss, to varying degrees of detail, the application of the OECD principles to nano-
(Q)SAR models (Kar et al., 2014a; Oksel et al., 2015a; Oksel et al., 2017; Oksel et al., 2015c; 
Tantra et al., 2015; Toropov and Toropova, 2015). Our current paper discusses the relevant 
considerations, which need to be taken into account when evaluating nano-(Q)SAR models 
according to the OECD principles in greater detail than these previous works. More careful 
consideration is given to relevant issues such as data quality and reproducibility of 
computational results. Section 2 presents an in-depth discussion of the issues relating to each 
of the five principles. Section 3 summarizes some of the key questions which need to be 
answered, along with more detailed considerations which need to be taken into account, when 
evaluating nano-(Q)SAR models according to these principles and indicates how these key 
questions may be used for an initial evaluation of nano-(Q)SAR models developed, in part, by 
members of the NanoSafety Modelling Cluster. Drawing upon expertise across this cluster of 
modelling projects, section 4 concludes with some take home messages.   
 
2. Discussion on the criteria for validating Nano-QSARs 
 
2.1. A defined endpoint 
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The endpoint in a (Q)SAR is defined as Òa measure of activity for chemicals made 
under specific conditionsÓ (OECD, 2007) and refers to Òany physicochemical property, 
biological effect or environmental parameter related to chemical structure that can be 
measured and modelledÓ (OECD, 2007). The first ÒOECD Principle for (Q)SAR validationÓ 
(OECD, 2004, 2007) states the need of using Òa clear endpoint definitionÓ. A well-defined 
endpoint is key to promote clarity regarding exactly what is being predicted by the (Q)SAR 
and to ensure that the selected endpoint is relevant for the purpose for which the (Q)SAR was 
developed and used. The OECD guidance proposes a range of specific considerations for the 
endpoint evaluation, namely whether (1) the scientific purpose, i.e. the modelled endpoint, is 
clearly defined; (2) the experimental protocol(s) used to generate the underlying data and 
other Òimportant experimental conditionsÓ are reported as well as the quality of the assays and 
sources for experimental error; (3) the units (supposing a numerical endpoint) of measurement 
are clearly defined; (4) the underlying data have been generated using sufficiently consistent 
experimental procedures; (5) the model has potential to (partially) address a defined 
regulatory need (i.e., the predicted endpoint has regulatory relevance) (OECD, 2004, 2007). 
In the following paragraphs, these points are discussed from the specific perspective of 
evaluating nano-QSAR models.  
Regarding the issue of addressing a regulatory need, for the purposes of this paper, this 
criterion is broadened to have greater general relevance, i.e. fitness-for-purpose for different 
possible applications of nano-QSARs, such as initial hazard screening in industry. Thus, what 
remains important is that the endpoint is relevant for the intended application of the model 
and, in keeping with this, that the exact endpoint being predicted is clear. 
Hence, in keeping with consideration (1) defined above, it is important that the 
terminology used to define the endpoint is sufficiently precise. For example the term 
ÒcytotoxicityÓ (Kar et al., 2014b; Kleandrova et al., 2014; Luan et al., 2014; Pathakoti et al., 
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2014; Puzyn et al., 2011; Toropov et al., 2012; Toropova et al., 2014; Toropova et al., 2015) 
may be considered to cover the output from a wide range of assays and a variety of cellular 
effects (Hu et al., 2009; Kroll et al., 2009; Lewinski et al., 2008; Oksel et al., 2015b) such as 
reduced viability (commonly considered cell death) (Lewinski et al., 2008), apoptosis and 
necrosis (Oksel et al., 2015b) (mechanisms of cell death) (Jin and El-Deiry, 2005), as well as 
Ð by some authors (Lewinski et al., 2008) Ð sub-lethal effects such as oxidative stress and 
inflammation or even genotoxicity. Other authors distinguish ÒcytotoxicityÓ from apoptosis 
and oxidative stress etc. (Nel, 2013). This illustrates the fact that the endpoint must be 
sufficiently described to avoid ambiguity in its interpretation. As a general rule of thumb, 
endpoint categories need to be distinguished in data and models between those that refer to 
specific measurements, e.g. different assays or specific ways of counting dead cells, and those 
that refer to groupings of biological relevance which can be measured in a variety of different 
ways, e.g. cytotoxicity. 
Clarity regarding terminology can be promoted by encouraging nano-(Q)SAR 
modellers to link their endpoint values to definitions from ontologies (Thomas et al., 2011) 
e.g. the BioAssay Ontology (BAO) (Visser et al., 2011). While the BAO definition of 
Òpercent cytotoxicityÓ (BAO_0000006) (Netzeva et al., 2005) is not itself 100% specific to a 
single way of defining cytotoxicity Ð in the text it lists several different assays which measure 
arguably different aspects of cytotoxicity including counting dead cells vs. different measures 
of cellular damage Ð if one browses down the BAO classification hierarchy, one will notice 
that there are subclasses to represent Òpercent apoptotic cellsÓ (BAO_0002006) and Òpercent 
dead cellsÓ (BAO_0002046) which are defined more specifically. Wherever possible, data 
should be annotated to the more specific type of endpoint, which in turn is linked to relevant 
assays, while the ontology hierarchy should capture the interrelationship between the specific 
and grouped endpoints. Modellers may then choose to combine data from different specific 
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endpoints in support of predictions of a general endpoint such as ÔcytotoxicityÕ, but this 
should be appropriately documented, as discussed below. Since the process of building 
ontologies requires that specific definitions are accepted by the scientific community and 
universally used, the eNanoMapper project worked towards creating an ontology specifically 
targeting this area Ð nanomaterial safety Ð including terminology for relevant assays, 
descriptors, and endpoints (Hastings et al., 2015), integrating content from BAO and other 
sources.  
One could argue that a nano-(Q)SAR endpoint, similar to those for (Q)SARs for small 
molecules, is most precisely defined if it is based on the output of a specific assay. This raises 
the question of whether or not it is appropriate to mix data obtained from different assays for, 
ostensibly, the same endpoint. Indeed, this touches upon the wider question of how to ensure 
minimal experimental heterogeneity, as per consideration (4) defined above, whilst having a 
sufficiently large number of tested chemicals for training and validating the model (Cronin 
and Schultz, 2003; Dearden et al., 2009; OECD, 2007). It has been previously argued that 
nano-(Q)SAR models should be developed using data obtained from a single source, 
supposing data for a sufficiently large number of nanomaterials were available from that 
source (Lubinski et al., 2013). However, it is recognised that this is not always a realistic 
expectation. Nanotoxicology data reported in the public domain are commonly generated 
according to a variety of different tests or, even when the same test (e.g. the Comet assay for 
genotoxicity assessment) is applied, according to different experimental systems/conditions 
(Golbamaki et al., 2015; Krug, 2014). 
The view that nano-QSARs should only be developed on data measured according to a 
single protocol under a single set of conditions is arguably reflected in the typically small 
datasets employed for nano-QSAR development (Oksel et al., 2015b). However, it is 
established in both the statistical community more broadly (Kaplan et al., 2014) and in 
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QSAR/QSPR studies in particular (Hawkins, 2004; Palmer and Mitchell, 2014) that, all else 
being equal, larger datasets support better predictive modelling and more robust validation 
statistics (see section 2.4 for more detailed discussion). Indeed, an interesting recent QSPR 
study indicated that mixing up literature data may yield models which are comparably 
predictive to models developed using data from a single experimental protocol in the same 
laboratory (Palmer and Mitchell, 2014). This suggests that it should not be assumed that data 
which are not perfectly experimentally consistent cannot be combined for modelling, albeit 
caution is still advisable. Even in the case that the inconsistency in experimental data is 
sufficient to significantly affect the ability to model merged datasets based on descriptors of 
nanomaterial structure alone, it may still be possible to merge the data via treating the 
experimental protocol variables as descriptors. Indeed, this approach has been applied in 
recent nano-QSAR studies (Cassano et al., 2016; Toropov and Toropova, 2015). Of course, in 
order to assess whether data are likely to be sufficiently inconsistent for their merging to be 
inadvisable or so that the inconsistency can be captured via treating the experimental 
variables as descriptors, it is crucial that the key experimental variables are consistently 
reported across data sources, which can be supported by use of ontologies (Hastings et al., 
2015; Marchese Robinson et al., 2015). Indeed, the wider need for minimum reporting 
standards is currently a key topic in the nanoscience community (Aberg, 2015; Marchese 
Robinson et al., 2016; Marquardt et al., 2013; Stefaniak et al., 2013). 
Regarding the units of measurement to be reported for numerical endpoints, as per 
consideration (3) defined above, the following question arises. Which dose (or concentration) 
units are most appropriate if the endpoint value in question is a dose-response or 
concentration-response statistic, e.g. an LC50 (Netzeva et al., 2005), or a lowest observed 
adverse effect level, i.e. LOAEL (Lewis et al., 2002)? Whilst the most appropriate 
dose/concentration units may be scenario-specific (Donaldson and Poland, 2013), it is 
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generally accepted that mass-based concentrations or doses are least appropriate (Cohen et al., 
2014; Donaldson and Poland, 2013; OECD, 2012). For small molecule chemicals, it is 
generally accepted that concentration response data should be expressed in terms of moles per 
litre and, indeed, some nano-(Q)SAR studies have reported concentration-response endpoints 
in moles per litre. However, strictly speaking, the notion of ÒmolesÓ is not applicable for 
many nanomaterials as they are not based upon a single-molecule species. Rather, particle 
number or surface area-based concentrations (or doses) are commonly advocated (Cohen et 
al., 2014; OECD, 2012). However, converting the mass-based concentrations (or doses) to 
these, more appropriate units, requires appropriate physicochemical measurements (e.g. 
specific surface area values or density values depending upon the calculation employed) 
(Cohen et al., 2014; OECD, 2012) to be made. 
The experimental endpoint data need to be of sufficiently quality to create sound 
models, which also raises some nano-specific issues (Marchese Robinson et al., 2016). Indeed, 
given that data quality may be considered related to the degree to which the data are clearly 
defined, including in terms of metadata availability, and are free of errors (Marchese 
Robinson et al., 2016), considerations (1-3), as defined above, are related to the topic of data 
quality. One particularly key, nanospecific data quality aspect is the potential for artefacts and 
misinterpretations that may arise with a variety of nano(eco)toxicology assays (Crist et al., 
2013; Handy et al., 2012; Kroll et al., 2009; Krug, 2014; Petersen et al., 2014). Some notable 
potential problems are as follows: (1) the potential for the nanomaterial to interfere with the 
assay readout such that this readout does not accurately correspond to the nominal endpoint 
(Kroll et al., 2009; Petersen et al., 2014); (2) contamination with endotoxin or residual solvent 
(used for sample preparation) triggering toxicity that is wrongly attributed to the nanomaterial 
(Crist et al., 2013; Krug, 2014; Petersen et al., 2014). Tests to exclude the possibility of assay 
interference have been proposed (Petersen et al., 2014), along with suggested test 
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systems/assays that are expected to be free of nanomaterial interference (Kroll et al., 2009; 
OECD, 2010) and assessment of endotoxin contamination and its potential significance for 
the test system are recommended (Crist et al., 2013; Petersen et al., 2014). Whether or not 
these issues were accounted for should be reported. 
The precise identification of the test substance is also a requirement for high quality 
data (Marchese Robinson et al., 2016; Przybylak et al., 2012). In the case of nanomaterials, 
this typically, but not necessarily (Marchese Robinson et al., 2016), requires that essential key 
physicochemical properties are reported (Marchese Robinson et al., 2016; Powers et al., 2006; 
Stefaniak et al., 2013). (Under certain circumstances, suitable identifiers might be sufficient to 
determine the nanomaterial being tested (Marchese Robinson et al., 2016)). For example, in 
contrast to small molecule chemicals, nanomaterials are typically polydisperse, hence the size 
distribution needs to be reported if physicochemical characterisation is used to identify the 
nanomaterials. N.B. It should be noted that the characterisation of the nanomaterials, in terms 
of their key physico-chemical properties, may also be considered relevant to definition of the 
applicability domain (see section 2.3). High variability of measured data depending on the 
experimental conditions is an issue particularly for nanomaterials, impacting on the 
characterisation of the materials (Worth et al., 2017). 
Another consideration typically argued to be related to data quality is the adherence to 
a standardised experimental protocol. However, the most appropriate way to adapt the 
existing standardised test procedures to the specific nanomaterial issues was still under 
discussion at the time of writing (OECD, 2009, 2013a, 2014a, b). A more detailed discussion 
of data quality and completeness considerations for nanomaterials was recently published 
(Marchese Robinson et al., 2016). 
When considering all these issues, one must bear in mind that nanoparticle safety 
assessment is a relatively young discipline; hence the requirements regarding endpoints and 
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characterisation of data and experimental protocols, which are specific to nanomaterials, are 
still being discussed in the community. Drawing upon the preceding discussion, we propose 
that any evaluation of a nano-QSAR according to the OECD requirement for a defined 
endpoint should entail consideration of the following key questions. Is a precise definition of 
the endpoint provided (e.g. an ontology annotation)?  Are the test methods / assays, along 
with the key experimental variables, used to generate the endpoint data documented and 
relevant for nanomaterials?  Are the data ÒreasonablyÓ experimentally consistent?  Are units 
provided for numerical endpoints? Have concentration / dose related units been converted 
from mass based units (e.g. into surface area based units)? Has the potential for nanomaterial 
interference with the assays been excluded? Has endotoxin or residual solvent contamination 
been assessed? Is the endpoint relevant for the intended application of the model? In 
summary, the most important requirement for providing Òa defined endpointÓ is the 
transparent and clear description of all relevant key parameters as discussed above, in order 
for the potential user of the nano-QSAR model to be able to judge whether the nano-QSAR 
model can be used for the intended purpose. 
 
2.2 An unambiguous algorithm 
 
The Òunambiguous algorithmÓ principle requires that the complete structure of the 
model, as well as the exact values of all the model parameters, should be made explicit.  This 
includes adequate description of the mathematical method employed for defining the 
relationship between the descriptors of the structure and the ÒactivityÓ endpoint of interest, as 
well as how descriptors are calculated (or measured). The complete dataset of substances, 
end-point and descriptor values, together with clearly defined training and test sets should be 
provided to the user. The remainder of this section is divided into subsections concerned with 
critical considerations which need to be taken into account when assessing compliance with 
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the principle of an Òunambiguous algorithmÓ: modelling algorithms (section 2.2.1), 
descriptors (section 2.2.2), variable selection (section 2.2.3) and model reproducibility 
(section 2.2.4). 
 
2.2.1. Modelling algorithms 
A (Q)SAR model is built via applying a statistical or machine learning algorithm to a 
training set, comprising a matrix of descriptor values with associated endpoint values. Certain 
algorithmic parameters, sometimes known as ÒhyperparametersÓ, which determine how the 
algorithm generates a model from this training set matrix may be tuned using internal 
validation data. With regard to data mining and machine-learning methods used to derive 
nano-(Q)SARs, there are no major differences compared to classical (Q)SAR analysis, 
therefore all the well-established algorithms (including but not limited to multiparametric 
linear regression, partial least squares, different types of neural network architectures, support 
vector machines, decision trees etc.) can also be employed (Fourches et al., 2010; Mitchell, 
2014). Recently, there has been renewed interest in the QSAR community regarding artificial 
neural networks, especially in Òdeep learningÓ (Baskin et al., 2016). However, given that it 
has been suggested that Òdeep learningÓ is particularly suited for analysis of large datasets 
(Baskin et al., 2016), whether it is suitable for the small datasets typically considered in nano-
QSAR analyses (Oksel et al., 2015b) is perhaps questionable. 
 
2.2.2. Descriptors 
The issue of the descriptors to be employed for nano-QSARs and the representation of 
the nanomaterial structural information from which these are derived represents the major 
difference between nano-QSARs and most QSARs, which are designed for small molecules 
(Cherkasov et al., 2014; Dearden, 2016). Although a large number (in the order of thousands) 
of (Q)SAR molecular descriptors have been defined so far (Consonni and Todeschini, 2010), 
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they are often inadequate to express the supra-molecular pattern governing the activity and 
properties of nanomaterials. However, here it should be noted that molecular descriptors may 
be used to build nano-(Q)SAR models under certain circumstances. For example, they have 
been successfully applied for the scenario in which all modelled nanoparticles comprise 
exactly the same core and variation arises from the molecular structure of the small molecule 
surface modifier, with descriptors calculated solely for this modifier (Kar et al., 2014a). Since 
nanomaterials based on fullerenes (e.g. C60) and their derivatives are based on well-defined 
molecular structures, it could be argued that molecular descriptors are adequate for modelling 
their effects. However, these nanomaterials may exist as agglomerates of fullerene molecules 
(e.g. ÒnC60Ó particles), with characteristics likely to depend upon sample preparation, 
including the dispersion protocol, rather than being solely determined by the fullerene 
molecular structures (Astefanei et al., 2015). It should be noted that molecular descriptors, 
calculated from SMILES representations (Weininger, 1988), have been applied for modelling 
of a variety of kinds of nanomaterials (Singh and Gupta, 2014), even though the 
nanomaterials in question cannot truly be represented by a SMILES string.   
One of the major challenges in the derivation of nano-(Q)SAR models is the fact that 
nanomaterials are typically not distinct chemical structures, but rather substances of more 
complicated structures, which often comprise core chemistries, multiple coatings and linkages 
between components (encapsulation, entrapments, amide linkages, etc.) of varying size 
distributions (Thomas et al., 2013). The extension of the Òsimilar compounds have similar 
propertiesÓ principle (Johnson and Maggiora, 1990), which underpins QSAR analyses 
(Golbraikh et al., 2014; Hansch and Fujita, 1964), to nanostructures is not trivial. Similarity of 
nanoparticles must accommodate many aspects other than chemical similarity, such as 
structural similarity including primary size, size distribution, shape, porosity and crystal 
structure (Burello and Worth, 2011; Gajewicz et al., 2012; Le et al., 2013; Puzyn et al., 2009), 
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whilst the potential presence of multiple coatings can further modify the material properties 
and should be taken into account when addressing nanoparticle similarity or defining their 
identity. Furthermore, the exchange between agglomerated and dispersed forms, as well as the 
formation of lipid and protein coronas, whose composition can be considered as a biological 
fingerprint of a nanoparticle, are also factors that define the identity of the nanomaterial for 
the toxicity assessment purposes (Walkey et al., 2014). Recent reviews discuss the 
relationship between nanomaterial structures / physicochemical characteristics and their 
biological effects in greater detail (Bai et al., 2017; Oksel et al., 2017). 
By definition, the nanomaterial is presented on a scale of at least one nanometer 
(Lvestam et al., 2010; Rauscher et al., 2013), which implies that a nanoparticle contains 
from dozens to billions of atoms. One can mention at least five features that characterize the 
nanomaterial and are not present at the level of single molecule or pure chemical. Firstly, the 
processing of nanomaterials often involves surface modification of different chemical nature 
to improve the dispersion stability Ð i.e., to prevent nanoparticles aggregation and deposition 
on the walls of the sample cells or container. Therefore, the molecular structure of the 
material that interacts with biomolecules is often different to the reported core nanomaterial. 
Secondly, whilst being transported to the tissue, the nanoparticles may come in contact with 
biomolecules of the dispersion medium, as the nanoparticles are often dispersed in surfactant 
or proteins solutions. Therefore, the properties of the core nanomaterial itself may be 
irrelevant for the (Q)SAR, if the co-solutes are not specified. Thirdly, the structure of a 
nanomaterial is not fully defined by chemistry alone. The nano-bio interactions may depend 
on molecular packing (e.g., crystalline or amorphous phase), size and shape etc. Fourthly, 
even when the main material is defined, a single nanoparticle might contain a macroscopic 
number of impurities or dopants. Fifthly, nanomaterials are typically not a single entity or 
even a small set of discrete entities. Rather, they may exhibit ÒpolydispersityÓ in terms of a 
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range of properties (Miller and Hobbie, 2013). For example, a nanomaterial may comprise a 
number of particles with the same chemical composition but distributed across a range of 
different sizes (Powers et al., 2007). 
Thus, a meaningful nano-(Q)SAR should arguably include the information about the 
surface chemistry, surface charge, crystalline structure, particle size and shape, the delivery 
vehicle or co-solute, and the dopants/impurities in addition to the chemical content of the 
particle. Ideally, information about the particle size distribution and, if relevant, other forms 
of ÒpolydispersityÓ should also be captured. This means, in practice, that more than one 
type/system of descriptors is often required for nano-(Q)SAR modelling. Moreover, the 
descriptors can be divided into two classes: ÒintrinsicÓ and ÒextrinsicÓ properties. The first 
class contains properties that are independent on the external conditions (e.g., on pH, the 
presence of proteins), whereas the second class describes changes in the structure dependent 
on the changing environment (Mikolajczyk et al., 2015). Taken together, these parameters 
make an analogue of a pure chemical in a standard molecular (Q)SAR. By this we mean that 
the combined set of ÒintrinsicÓ and ÒextrinsicÓ properties give rise to biological effects and, if 
suitably characterised using descriptors, can serve as the basis of a nano-QSAR. 
Given this structural complexity, it follows that representation formats for 
nanomaterials are definitely more complicated than those of single-molecule chemicals, and 
consequently this subject deserves separate and careful assessment. One such proposed format 
is the ISA-TAB-Nano Material file and its associated data files (Marchese Robinson et al., 
2015; Thomas et al., 2013). The format used to represent the nanomaterial, even before 
starting any descriptor calculation, may have huge impact on the final model and therefore 
should be carefully specified. 
Novel and more appropriate types of nano-descriptors are being developed, such as 
features derived from quasi-SMILES, encoding physicochemical properties and/or 
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experimental conditions using string labels (Cassano et al., 2016; Toropov et al., 2015; 
Toropov and Toropova, 2015; Toropova et al., 2011; Toropova et al., 2015), descriptors 
derived from molecular graph or the graph of atomic orbitals theory (Puzyn et al., 2009) and 
features derived from quantum-mechanical (QM) calculations (e.g. electron distribution, 
ionisation potential, electron affinity, surface reactivity, band gap, electronegativity and 
enthalpy of formation) (Gajewicz et al., 2015; Puzyn et al., 2011). Mechanistic justification 
for these QM descriptors is provided in the cited references (Gajewicz et al., 2015; Puzyn et 
al., 2011). Other relevant descriptors that cover the biological activity of nanomaterials, such 
as protein adsorption energies, can be calculated using coarse-grain modelling (Lopez and 
Lobaskin, 2015). 
The exact method and the software used to derive these descriptors should be stated 
explicitly. For example, MOPAC (http://openmopac.net/) is a popular semi-empirical 
quantum chemistry program for deriving QM descriptors. However, in order to reproduce the 
results, the complete crystal structure and the optimised geometry of the nanoparticle, or 
representative cluster built from the bulk crystal structure, must be available (Gajewicz et al., 
2015). Additionally, the exact QM method used to perform the calculations should be 
provided, since different methods (e.g., PM3, PM6, PM7) may lead to substantially different 
results. Furthermore, semi-empirical models, whilst allowing for descriptors to be calculated 
relatively quickly, may lead to serious errors, in particular if the considered derivatives 
include metals. (Nonetheless, nano-QSAR investigations suggest descriptors derived from 
semi-empirical calculations can still yield reasonable models (Gajewicz et al., 2015; Puzyn et 
al., 2011)). Thus, it is advisable to validate the semi-empirical results by using rigorous ab 
initio methods (e.g. CCSDT(2), CASSCF/CASPT2) and reasonably extended basis sets (Coe 
et al., 2013; Serrano-Andres et al., 2009).  
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Experimentally derived properties also serve as suitable descriptors for developing 
nano-(Q)SARs, as they are especially useful for expressing size distribution, agglomeration 
state, shape, porosity and irregularity of the surface. A potentially useful source for deriving 
structural information of nanoparticles is images taken by scanning microscopy (SEM), 
transmission electron microscopy (TEM), or atomic force microscopy, where descriptors are 
calculated using image analysis techniques (Gajewicz et al., 2015). Other experimental data 
which may provide descriptors for nano-QSAR include zeta potential measurements (Cassano 
et al., 2016). To ensure consistency with the requirements of the second OECD Principle, the 
experimental protocol, the laboratory conditions and the algorithms used to calculate those 
descriptors should be provided in detail when experimentally derived descriptors are used in 
nano-(Q)SARs. This is demonstrated in the following examples:  
¥ The size of nanomaterials can be determined by different experimental methods. TEM 
typically measures the primary size of the nanoparticles (Murdock et al., 2008), but 
Dynamic Light Scattering (DLS) measures the Òhydrodynamic diameterÓ which is an 
effective diameter calculated based on the assumption that the particles are spherical 
(Baalousha and Lead, 2012; DLA, 2011). Indeed, the size measured via DLS may also 
reflect the presence of aggregates/agglomerates (DLA, 2011) hence may be 
significantly larger than primary size values. 
¥ Zeta potential is an important characteristic of the nanoparticle surface that determines 
the long-term stability of the nanoparticle dispersions. Zeta potential measurement 
techniques (e.g., light scattering and agarose gel electrophoresis) allow one to evaluate 
the surface charge of nanoparticles in the medium. The exact conditions under which 
zeta potential is measured should be available, as various factors (notably medium 
composition, sample pH, serum incubation) can significantly affect the measured 
values (Cho et al., 2012; Walkey et al., 2014; Worth et al., 2017). 
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¥ The composition of the protein corona may be modified when the nanoparticles move 
from one compartment to the other. The biological fluid, in which the corona 
composition is measured, should be exactly known (Le et al., 2013). 
Interestingly, experimentally-derived descriptors can be also used for calculating new types of 
theoretical descriptors, such as descriptors based on the ÒLiquid-Drop ModelÓ (LDM 
descriptors) (Sizochenko et al., 2014). The model can be used in order to encode nanoparticle 
aggregates in a solution. In LDM, the aggregate is represented as a spherical drop, where 
elementary nanoparticles are densely packed and the density of the aggregate is equal to the 
mass density. Then, the five following descriptors can be easily calculated: Wigner-Seitz 
radius (the minimum radius of the interactions between the elementary nanoparticles), the 
number of nanoparticles in the aggregate, the number of nanoparticles on the surface, the 
surface-to-volume ratio and the aggregation parameter. It is worth mentioning that the same 
scheme can be used to describe volume-related features of single nanoparticles. In such a 
case, a nanoparticle is treated as a cluster (ÒaggregateÓ) of atoms (i.e. LDM represents a single 
nanoparticle built up from atoms as the basic elements) (Sizochenko et al., 2014). 
 
2.2.3. Variable selection 
In order to select the descriptors employed for building a nano-QSAR model, a combination 
of mechanistic expertise and statistical variable selection may be employed, with the latter 
commonly referred to as Òfeature selectionÓ. Feature selection may be appropriate for two key 
reasons: (1) reducing the number of descriptors might avoid overfitting the training data, a 
scenario in which the model parameters are adjusted to predict the training set endpoint values 
well at the expense of true predictivity on data not seen during training; (2) a smaller number 
of descriptors makes expert assessment of the mechanistic basis for the model (see section 
2.5) more manageable (Cherkasov et al., 2014).  
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A commonly quoted heuristic in the QSAR literature, attributed to the work of Topliss and 
Costello (Topliss and Costello, 1972), is that the ratio of compounds : descriptors should be 
greater than or equal to 5:1, at least when using simple linear regression methods (see section 
2.2.1) (Cherkasov et al., 2014; Dearden et al., 2009). In the case of the typically small datasets 
used in nano-QSAR studies (Oksel et al., 2015b), sometimes of the order of 20 instances or 
less, this would imply very few descriptors should be considered. Indeed, according to the 
analysis of Topliss and co-workers, the probability of finding chance correlations in 
traditional multiple linear regression models is related to the total number of descriptors 
evaluated, via statistical procedures, rather than the final number included in the model 
(Topliss and Costello, 1972; Topliss and Edwards, 1979), so it cannot reasonably be claimed 
that a nano-QSAR model is compliant with the so-called Topliss and Costello rule if the ratio 
is reached via statistically evaluating a larger set of descriptors for inclusion in the model. 
However, it should be noted that the seminal work of Topliss and co-workers (Topliss and 
Costello, 1972; Topliss and Edwards, 1979) was based on specific variable selection 
approaches in the context of traditional multiple linear regression analysis and it cannot be 
assumed that their findings are necessarily applicable to all other techniques. Furthermore, 
these authors did not actually propose a hard and fast rule. Hence, rather than condemn a 
nano-QSAR model as worthless if it violates the so-called Topliss and Costello rule, it is more 
appropriate to be judicious regarding the descriptors considered for evaluation on mechanistic 
grounds, where possible, and employ rigorous statistical techniques, e.g. Ôexternal cross-
validationÕ (Hawkins, 2004; Low et al., 2011) and y-scrambling (Rucker et al., 2007) 
discussed in section 2.4, in combination with assessment of the mechanistic plausibility of 
obtained correlations (see section 2.5) to ascertain whether a nano-QSAR model really is 
based on chance correlations and cannot be trusted to make reliable predictions for unseen 
data.  
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A variety of approaches for statistical feature selection exist (Ferreira and Figueiredo, 
2012; Guyon and Elisseeff, 2013). A number of these are based on the so-called Òrelevance 
and redundancyÓ criteria (Ferreira and Figueiredo, 2012) that, in the terminology of QSAR, a 
good set of descriptors should be well correlated with the modelled endpoint and poorly 
correlated with each other. However, different measures of variable association might give 
different results and descriptors which appear highly correlated according to some measures 
may not be truly redundant (Guyon and Elisseeff, 2013). Statistical feature selection remains 
an active area of research. 
If feature selection algorithms are applied, both the original and the reduced sets of 
data should be made available to the user, including the rules and mathematical formulae used 
to select, prioritise or cluster the data. Moreover, values of the steering parameters for the 
algorithms (if any) should be provided in detail. 
Feature ranking methods, which rank descriptors according to their relevance to 
modelling the endpoint as may be estimated using a variety of techniques (Ferreira and 
Figueiredo, 2012), might be used for the mechanistic interpretation of models. For example, a 
mechanistically comprehensible descriptor found to show high (positive) association with an 
endpoint could yield insights into the structural factors driving the modelled endpoint.    
 
2.2.4. Model reproducibility 
Reproducibility of the models, including easy transfer and exchange across different 
platforms, is an important issue in QSAR modelling (Tetko et al., 2017), which also applies to 
the case of nano-QSAR analysis (Helma et al., 2017). Indeed, the reproducibility of 
computational science more generally has been a key concern in the recent scientific literature 
(Editorial, 2014). 
A variety of formats exist for documenting QSAR models, for the purpose of creating 
model-specific records in online or in-house repositories, in order to facilitate their reuse. 
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These formats and repositories were recently reviewed (Tetko et al., 2017). One such format, 
established over a decade ago by the European CommissionÕs Joint Research Centre (JRC), is 
the (Q)SAR Model Reporting Format (QMRF), designed to document QSAR models in 
keeping with the OECD principles [(Pavan and Worth, 2008); http://qsardb.jrc.it/qmrf]. In a 
recent project by JRC it has been used in a format extended for nanomaterials to compile an 
inventory of currently existing nano-QSARs/QSPRs (Worth et al., 2017). The eNanoMapper 
project developed a resource for generating QMRF reports for nano-QSAR models (Drakakis 
et al., 2016). However, this format only supports documentation of human readable, free text 
descriptions of the relevant details required to reproduce the models, along with encouraging 
links to relevant software and structural files. In practice, this might not be sufficient to 
(easily) reproduce the model. The QsarDB format [(Ruusmann et al., 2014, 2015; Tetko et al., 
2017); http://qsardb.org], in contrast, seeks to document the QSAR models in a machine-
readable fashion, designed to be readily parsed by appropriate software tools to reproduce the 
models. Notably, the QsarDB format uses the Predictive Model Markup Language [(Tetko et 
al., 2017); http://dmg.org/pmml/v4-3/GeneralStructure.html], where applicable, to represent 
the structure of the model itself in a software independent machine-readable fashion. This is 
complemented with information about the descriptors, endpoint values and chemicals in the 
training and test sets. For example, the nano-QSAR model of Puzyn and co-workers for 
inorganic nanoparticle cytotoxicity (Puzyn et al., 2011) has been recorded within the QsarDB 
database (Piir, 2014), with the structure of the final derived regression model documented 
using PMML.  
However, this example (Piir, 2014) also highlights potential challenges for 
representing nano-QSAR models in this fashion. It is implied that the nanoparticles for which 
descriptors are calculated can be represented using a CAS number, which is clearly 
inadequate for describing nanomaterials, as opposed to small molecule chemicals. Future 
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work should consider whether the existing model reporting formats can be supplemented with 
links to suitable representations of nanomaterial structures, e.g. based on the Material file of 
ISA-TAB-Nano and linked data files (Burello, 2017; Marchese Robinson et al., 2015; 
Thomas et al., 2013), to better support the reproducibility and re-use of nano-QSAR models.    
The JaqPot Quattro (JQ) nanomaterial web modelling platform (Chomenidis et al., 
2017) , developed in the context of the eNanoMapper project, is linked to the eNanoMapper 
database (Jeliazkova et al., 2015), which integrates diverse and heterogeneous information to 
adequately represent complex nanomaterial structures.  Among other functionalities, JQ 
facilitates the automatic creation of reproducible nanoQSAR models in the form of ready-to-
use web resources, that can be accessed either through the system API or through a user-
friendly interface. Additionally, JQ creates PMML representations of the produced 
nanoQSAR models. Model validations and end-point predictions are performed either by 
feeding data from the eNanoMapper database or by manually entering the descriptor values.  
For example, the model developed by Gajewicz co-workers for predicting log(1/LC50) toxicity 
to the human keratinocyte cell line (HaCaT) cell line (Gajewicz et al., 2015) has been 
generated using the JQ functionalities and is offered to the community as a web resource and 
application (http://www.jaqpot.org/m_detail?name=gaj-18-linear).    
 
2.3. A defined domain of applicability 
 
The OECD guidance defines the Òapplicability domainÓ as follows (OECD, 2007): 
ÒThe applicability domain of a (Q)SAR model is the response and chemical structure space in 
which the model makes predictions with a given reliabilityÓ. In this definition, chemical 
structure can be expressed by physicochemical and/or fragmental information, and response 
can be any physicochemical, biological or environmental effect that is being predictedÓ.  
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Thus, the ultimate purpose of defining the ÒdomainÓ is to ensure the model is not used 
to make predictions for chemicals for which the predictions are expected to be unacceptably 
unreliable (Gadaleta et al., 2016; Hanser et al., 2016). However, what this is interpreted to 
mean in practice varies considerably and there are a plethora of different approaches to 
characterising the applicability domain (Hanser et al., 2016). Since QSAR models are 
obtained using statistical algorithms based on the observed trends within the training set, there 
is no reason to expect the relationships they capture to be applicable to regions of Òchemical 
spaceÓ lying outside the training set chemicals. Hence, various approaches to defining the 
applicability domain are based on ensuring the model does not extrapolate outside the 
chemical space of the training set in terms of relevant descriptors (Hanser et al., 2016). This 
might be quantified in terms of a ÒleverageÓ threshold, as employed for applicability domain 
characterization for one of the nano-QSAR models of Puzyn and co-workers (Puzyn et al., 
2011). However, a variety of different kinds of information might be considered when 
evaluating the applicability domain, including direct estimations of the uncertainty in 
individual predictions, coupled with a suitable threshold for rejecting a prediction as being 
unacceptably unreliable (Hanser et al., 2016). It should be understood that these seemingly 
disparate approaches are all concerned with the central question underpinning the concept of 
an applicability domain: is the prediction returned for this new chemical (or, in the context of 
nano-QSARs, nanomaterial) of acceptable reliability, or should it be rejected? Nonetheless, it 
should be noted that Hanser et al. (Hanser et al., 2016)  have proposed breaking down this 
assessment into a multi-step decision framework, based upon consideration of different kinds 
of information at each stage: firstly, decide whether the model can be applied at all to make a 
prediction for the current use case (applicability assessment); secondly, decide whether the 
prediction is reliable enough for the current use case (reliability assessment); finally, decide 
whether a clear decision can be made based on the prediction (decidability assessment).  
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The recent QSAR literature has increasingly focused on approaches which seek to 
directly estimate the reliability of predictions for new chemicals (Dragos et al., 2009; Hanser 
et al., 2016; Lindh et al., 2017; Sushko et al., 2010), investigating a variety of measures 
reflecting the predictive error: standard deviation calculated from the ensemble of models 
(Tetko et al., 2008), bagged variance (directly available from Random forest models), 
estimating the error model of a machine learning algorithm via another machine learning 
algorithm (Sheridan, 2013), Kullback-Leibler (K-L) divergence probability distributions 
(Wood et al., 2013), local estimates of error (Clark, 2009; Sahlin et al., 2014; Sheridan, 2013) 
or confidence (Helma, 2006), sensitivity analysis and most recently, conformal prediction 
(Lindh et al., 2017; Norinder et al., 2014). An overview of the importance of and methods to 
characterize uncertainty is provided in a series of recently published contributions    (Dragos 
et al., 2009; Hanser et al., 2016; Iqbal et al., 2013; Lindh et al., 2017; Sahlin, 2014; Sahlin et 
al., 2013; Sushko et al., 2010). The current trend of moving away from similarity as an 
assumed measure of applicability domain and predictivity (Sheridan et al., 2004) through 
adding additional metrics (Keefer et al., 2013; Sheridan, 2012) and finally realising that 
similarity is redundant (Sheridan, 2013), reflects a view that the essential need is not 
delineating the ÒdomainÓ, but being able to estimate the uncertainty of predictions. 
In keeping with the preceding comments regarding the potential need to take account 
of a variety of different kinds of information when assessing the applicability domain, another 
key question to ask is the following one: is the compound in the applicability domain of the 
model in terms of its mechanistic and metabolic profile? This shifts the weight of the ÒdomainÓ 
problem from purely statistical analysis to the mechanistic / metabolic definition of 
applicability domain. These questions are also directly related to the mechanistic 
interpretation of the model; the modeller assumes that a given combination of descriptors has 
a concrete meaning in the context of the studied toxicity mechanism. Thus, the assumed 
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mechanism, or set of mechanisms in the case of a non-linear modelling technique which is 
able to model toxicity data arising from multiple mechanisms, should be the same for training 
nanoparticles and nanoparticles for which the predictions are made. Regarding whether the 
metabolic profile, which is linked in turn to the mechanism of action, for a new nanomaterial 
reflects the metabolic profile of the nanomaterials in the training set, it should be 
acknowledged that this information may not be available in practice, yet may become 
increasingly available in the future (Lv et al., 2015). 
Current (Q)SARs for nanomaterials mostly use descriptor-based approaches to 
applicability domain estimation (Gajewicz et al., 2012; Gajewicz et al., 2015; Liu et al., 
2013b; Puzyn et al., 2009; Puzyn et al., 2011). However, we can make the following key 
recommendations. Firstly, we recommend statistical approaches to directly estimating the 
prediction reliability which were discussed above (e.g. a conformal prediction framework 
(Lindh et al., 2017)). Secondly, we make the following key recommendations which are 
specific to nano-QSAR modelling:  
¥ If a nano-(Q)SAR model is specifically developed for a certain type of nanostructure 
(for example fullerenes, carbon nanotubes, metal oxides etc.), the AD of the model 
may be considered limited to this type of nanomaterial. 
¥ A single nanostructure is often composed of multiple different components (e.g. core 
and coating). Theoretical features or molecular fragments can be obtained in this case 
for all different components and used as descriptors in a nano-(Q)SAR model.  In the 
process of examining the similarity of a query substance to the training set, 
comparisons should be made among equivalent components, i.e. the core of the new 
substance should be compared against core components in the training set and the 
same should happen for the coatings, taking into account the order of coatings in the 
formation of the nanomaterials.  
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¥ When experimental measurements are used as descriptors, the experimental protocols 
and conditions for measuring the descriptors in the query nanostructure and the 
training set should be sufficiently consistent. 
¥ Data on the regulation of genes, production of metabolites, interactions with all 
relevant proteins, such as information on the protein corona (i.e., proteins that are 
adsorbed onto the surface of nanoparticles), etc. (collectively known as ÒomicsÓ data) 
can be used as quantitative experimental descriptors. Furthermore, they can uncover 
fundamental mechanisms of nano-bio interactions and be used for defining the 
mechanistic domain of the model (Walkey et al., 2014). Again, experimental 
procedures and biological fluids for obtaining ÒomicsÓ data should not differ 
significantly between query substances and the training set.  
Compared to classical (Q)SAR modelling, it seems more important to achieve a 
balance between the level of confidence in the predictions of a nano-(Q)SAR and its scope. 
For example, should a substance with similar core, but dissimilar coatings to those present in 
the training set (or vice versa) automatically be excluded from the applicability domain? Is an 
in silico prediction totally unreliable if experimental structural descriptors (such as size or 
shape) are measured under different experimental protocols? (A cautious response would to 
be say, ÒyesÓ, however it is not necessarily the case that the differences in, say, size measured 
via two slightly different protocols are sufficiently large to significantly affect the model 
predictions. Hence, this question should ideally be evaluated empirically for different 
scenarios.) The challenge for the nano-(Q)SAR research community is to develop new 
methods for defining the applicability of a model, taking into account the above 
considerations, in order to broaden the applicability domain without compromising the 
reliability of predictions. 
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2.4. Appropriate measures of goodness-of-fit, robustness and predictivity for 
nanomaterial models 
 
The fourth OECD Validation Principle (OECD, 2007) expresses the need to perform 
statistical analysis to establish the performance of a model, which consists of an internal 
validation process (i.e., measures of goodness-of-fit and robustness) followed by the external 
validation (i.e., measures of predictivity). The statistical validation techniques described in 
this subsection should be considered in combination with any knowledge about the 
applicability domain of the model, since the choice of nanomaterials during model 
development and validation strongly affects the assessment of performance. 
Predictions for nanomaterials in the training set, made using the final model derived 
from the whole training set, can be used to assess the goodness-of-fit of the model, which is a 
measure of how well the model accounts for the variance of the response in the training set 
and, most importantly, whether the model is statistically significant. This type of error 
estimate is known as the apparent error rate. It will generally suffer from substantial 
optimistic bias, since many algorithms can fit a given training set perfectly or near perfectly, 
and thus yield an apparent error of zero or near zero. A model that is not statistically 
significant, or that is significant but of poor fit, cannot be expected to be useful for predictive 
purposes.  
The robustness of a model refers to the stability of its parameters and consequently the 
stability of its predictions when a perturbation (e.g. deletion of one or more nanomaterials) is 
applied to the training set, and the model is regenerated from the perturbed training set. If the 
model is not robust to small perturbations in the training set, it is unlikely to be useful for 
predictive purposes. 
Predictions for nanomaterials in the test set(s) are used to assess the predictivity 
(predictive ability, predictive capacity, or predictive power) of a model, which is a measure of 
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how well the model can predict new data not used during model development. N.B. Certain 
training set resampling techniques, discussed in section 2.4.1, may also be considered as 
internal validation, albeit if applied with care may avoid optimistically biased performance 
estimates, e.g. so-called Ôexternal cross-validationÕ (Hawkins, 2004; Low et al., 2011)  
In order for a statistical model to be useful for predictive purposes, it should be 
developed from a sufficiently large and representative amount of information regarding the 
biological activity and should only contain relevant variables. A variety of statistical 
validation techniques are available for assessing the goodness-of-fit, robustness and 
predictivity of models, and a variety of statistics are routinely used to express these aspects of 
model performance. However, information related to nanosafety is usually found in the form 
of small (i.e. limited number of samples) datasets (Oksel et al., 2015b). It is commonly known 
that the smaller the number of samples available in the training/test data sets, the less reliable 
the error rate estimate will be.  
 
2.4.1. Statistical validation techniques 
A number of statistical validation techniques can be used to assess the predictive 
ability of a QSAR model based upon resampling or permuting the available data used to build 
the final model. (Resampling techniques entail rebuilding the model on subsets of the data 
and evaluating on the remaining data, as explained below for different techniques.) In 
principle, these techniques are equally applicable to nano-QSAR models although the 
typically small size (Oksel et al., 2015b) of nano-QSAR datasets makes certain considerations 
particularly pertinent, as will be explained below. The most popular ones are described next; 
more extensive description of the statistics and validation techniques can be found elsewhere 
(Alexander et al., 2015; EChA, 2008; Worth et al., 2005). 
The training/test set splitting is a validation technique based on the splitting of the 
dataset into a single training set and a test set, unlike the resampling techniques described 
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below. The model is derived from the training set and the predictive power is estimated by 
applying the model to the test set. The splitting is performed by either randomly or 
systematically (e.g., taking every third compound from the set sorted according to the 
descending endpoint value) selecting the instances (i.e. nanomaterials in the current context) 
belonging to the two sets. 
Cross-validation (CV) is the most common resampling validation technique, where a 
number of modified datasets are created by deleting one or a small group of nanomaterials 
from the data in such a way that each nanomaterial is removed away once and only once. 
From the original dataset, a reduced dataset (i.e., training set) is used to develop a partial 
model, while the remaining data (i.e., test set) are used to evaluate model predictivity (Efron, 
1983). The simplest cross-validation procedure is the leave-one-out (LOO) technique, where 
each nanomaterial is removed, one at a time. Using this method, given n nanomaterials, n 
reduced models are calculated, each of these models is developed with the remaining n-1 
nanomaterials and used to predict the response of the deleted nanomaterial. The averaged (or 
pooled, i.e. aggregated across all n predictions) performance of the n reduced models is 
reported as the LOO cross-validated performance. Other cross-validation procedures, such as 
the leave-many-out (LMO) technique, try to introduce a larger perturbation in the dataset by 
removing more than one nanomaterial at each step. In K-fold cross-validation, the training set 
is divided into K sets of approximately equal size, each one being used in turn as a test set for 
evaluation of models build on the remaining data. 
Bootstrap resampling or bootstrapping is another technique to perform statistical 
validation (Braga-Neto and Dougherty, 2004; Wehrens et al., 2000). In a typical bootstrap 
validation, k groups of size n are generated by a repeated random selection, with replacement, 
of n nanoparticles from the original dataset. For any one of the k groups, some of these 
nanoparticles can be included in the same random sample several times, while other 
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nanoparticles will never be selected. Each bootstrap sample is treated as a training set, used to 
build the model, whilst the corresponding test set is the set of nanoparticles not selected for 
the bootstrap sample. This procedure of building training sets and test sets is repeated many 
times to obtain significant performance statistics. It should be noted that different variations, 
meaning different ways of estimating predictive performance, of the basic premise exist 
(Braga-Neto and Dougherty, 2004). 
Regarding which resampling techniques, whether a variant of cross-validation or 
bootstrap resampling, are most appropriate for evaluation of the typically small (Oksel et al., 
2015b) datasets used in nano-QSAR studies, the discussed techniques may be considered to 
have various strengths and weaknesses. It has been argued that, for small datasets, cross-
validation is preferable to using a single partition into training and test sets, as the cross-
validation estimate of model performance is likely to be more reliable (Hawkins, 2004; 
Hawkins et al., 2003). It has further been argued that cross-validation may even underestimate 
predictive performance (Hawkins et al., 2003). Regarding the suitability of different cross-
validation schemes for small datasets, cross-validation schemes, especially the LOO approach, 
have been suggested to suffer from considerable variance and can yield outliers which are 
highly misleading as to the true predictive performance (Braga-Neto and Dougherty, 2004). 
(However, it has elsewhere been suggested that LOO estimators are preferrable for small 
datasets (Hawkins, 2004)). Bootstrap estimators are suggested to be more robust, albeit to 
produce more biased results (Braga-Neto and Dougherty, 2004). Finally, it should be noted 
that heuristic guides to the minimum size of the datasets required for reliable modelling 
results, especially for nanomaterials, have been proposed elsewhere (Lubinski et al., 2013). 
Y-scrambling or response permutation testing is another widely used technique to 
check the robustness of a model, and to identify models based on chance correlation, i.e. 
models where the independent variables (descriptors in this context) are correlated to the 
  
33 
 
response variable (the endpoint in this context) by chance, within the available data. The test 
is performed by calculating the quality of the model obtained after randomly modifying the 
sequence of the response vector (e.g. the vector of measured biological activities for each 
nanomaterial), i.e. by assigning to each nanomaterial a response randomly selected from the 
true set of responses (Lindgren et al., 1996). If the original model has no chance correlation, 
there is a significant difference in the quality of the original model and that associated with a 
model obtained with random responses. The procedure is repeated many times. In order for 
Y-scrambling to be valid, the ÔentireÕ modelling protocol (including statistical selection of 
descriptors and algorithmic parameters, if applicable) should be repeated each time (Lindgren 
et al., 1996; Rucker et al., 2007) 
Finally, it should be noted that the techniques described in this section (2.4.1) are also 
advocated as means of assessing model robustness (Chirico and Gramatica, 2011, 2012; 
Golbraikh and Tropsha, 2002; Gramatica, 2007, 2013). 
 
2.4.2. Statistics for assessing goodness-of-fit and predictivity of regression models 
Regression models are mathematical models, linear or non-linear, that attempt to 
numerically explain the observed values of a (biological activity) endpoint variable in terms 
of several independent or predictor variables. 
To assess goodness-of-fit, the coefficient of multiple determination, R
2
, is calculated 
for the training set. R
2
 estimates the proportion of the variation of the endpoint variable that is 
explained by the model. However, the value of R
2
, for the training set, can generally be 
increased by adding additional predictor variables to the model, even if the added variable 
does not contribute to reduce the unexplained variance of the dependent variable. This can be 
avoided by using other statistical parameters such as the adjusted R
2
 adjusted for degrees of 
freedom, R
2
adj, or the explained variance in prediction, Q
2
. In contrast to R
2 
for the training set, 
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the values of R
2
adj and Q
2
 do not increase if an added variable to the equation does not reduce 
the unexplained variance (Massart et al., 1997). 
The strengths and weaknesses of R
2
 as a measure of goodness-of-fit and of assessing 
predictive power for QSAR models were recently discussed (Alexander et al., 2015). It should 
be noted that, when applied as a measure of true predictive performance on an external test set 
(section 2.4.4), there is no need to adjust the statistic according to the number of descriptors 
used.  
From the calculated and observed dependent variable values, the standard error of 
estimate, s, can be obtained. The standard error of estimate measures the dispersion of the 
observed values, and a smaller value of s may indicate a higher reliability of the prediction. 
However, a standard error of estimate smaller than the experimental error of the biological 
data is an indication of an overfitted model (Wold et al., 1984). 
Other recent articles also present detailed evaluations of a range of statistics for 
characterising the predictive power of QSAR models (Gramatica and Sangion, 2016; Roy et 
al., 2017; Roy et al., 2016; Todeschini et al., 2016). Likewise, it has elsewhere been suggested 
that an analysis of residuals should be performed, with a view to detecting bias (systematic 
error) in regression predictions (Roy et al., 2017). 
For the avoidance of doubt, it should be reiterated that whether these statistics 
represent unbiased estimates of the predictive power of a model is related to the set of 
instances (i.e. nanomaterials in the current context) for which they are calculated. If they are 
estimated by comparing the predictions of the model to the training set endpoint values, they 
will be optimistically biased. If they are used to compare endpoint values to predictions 
obtained from suitable resampling schemes (section 2.4.1) or, ideally, robust external 
validation (section 2.4.4), they may more reasonably be considered to quantify the predictive 
performance of a model.  
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2.4.3. Statistics for assessing goodness-of-fit and predictivity of classification models 
Classification models assign nanoparticles into two or more pre-defined categories. In 
a classification model, the results of the classification can be arranged in the so-called 
confusion or contingency matrix, where the rows represent the experimentally determined 
classes, while the columns represent the predicted classes assigned by the model. The 
goodness-of-fit of a classification model can be assessed in terms of its Cooper statistics 
(Cooper et al., 1979). 
The classification ability of a classification model depends on the particular dataset of 
nanomaterials used, especially if it is a small one. It is therefore useful to report some measure 
of the variability associated with the classifications, which indicates whether the classification 
performance of the model would vary significantly if it had been assessed with a different set 
of nanomaterials. To estimate confidence intervals for the Cooper statistics, the bootstrap re-
sampling technique can be used (Braga-Neto and Dougherty, 2004; Wehrens et al., 2000; 
Worth and Cronin, 2001). To compare the performances of a number of classification models, 
the Receiver Operating Characteristic (ROC) curve can be used (Lusted, 1971). In the ROC 
graph, the X-axis is 1-specificity (false positive rate) and the Y-axis is the sensitivity (true 
positive rate). An index of the performance of a classification model is the area under the 
curve. The predictive performance of a classification model can be evaluated by the 
proportion of misclassifications, e.g. as estimated with the leave-one-out method or with 
confidence intervals for a binomial proportion (Newcombe, 1998; Ross, 2003). However, 
estimating the overall percentage of misclassifications can be a poor measure of model 
performance in the case that the considered data are drawn disproportionately from one class 
(Baldi et al., 2000; Gorodkin, 2004). 
Reporting the observed error rate without estimated confidence intervals is of limited 
value. Given the study of a particular population, the true error rate constitutes an inherent 
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property of the model. The observed error rate is only an estimate and depends largely on the 
adopted sampling strategy. Confidence intervals for the statistic of interest are of particular 
importance in scenarios comprising small data sets such as nanomaterials ones (Berrar et al., 
2006a, b; Oksel et al., 2015b). 
The same comments, made at the end of section 2.4.2, regarding whether the 
calculated statistics for regression models quantify goodness-of-fit or predictivity also apply 
for the statistics calculated for classification models. 
 
2.4.4. Evaluating the predictivity of models 
One of the most important characteristics of a QSAR model is its predictive power, i.e. 
the ability, in the current context, of the model to predict accurately the (biological) activity of 
nanomaterials that were not used for model development. The resampling techniques 
discussed in section 2.4.1 are commonly described as internal validation techniques that 
cannot directly estimate the true predictive ability of a model on unseen data (Chirico and 
Gramatica, 2011, 2012; Golbraikh and Tropsha, 2002; Gramatica, 2007, 2013).However, it 
should be noted that some so-called internal validation procedures, such as cross-validation, 
need not necessarily yield optimistically biased estimates of model performance, if none of 
the selection of model parameters and descriptors is based on the nanoparticles used to assess 
model performance (Hawkins, 2004). Cross-validation carried out in this fashion may be 
termed 'external cross-validation' (Low et al., 2011). 
Nonetheless, true external validation (Chirico and Gramatica, 2011, 2012; Gramatica, 
2007, 2013; Tropsha, 2010; Tropsha et al., 2003) of the final model on data not seen during 
model development should be the ultimate aim.  In principle, the predictivity of a model 
should be estimated by comparing the predicted and observed values/classes of a sufficiently 
large and representative external test set of nanomaterials that were not used in the 
development of the model. However, external validation can be difficult to assess in a 
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meaningful way when data of sufficient quality are scarce. For this reason, a common practice 
is to split the available dataset into a training set, used to develop the model, and an external 
test set, used to assess the predictive capability of the model. (Indeed, if data are only 
available for a very small number of nanoparticles, the use of cross-validation protocols, 
suitably adapted to avoid optimistic bias, may yield a more reliable estimate of predictive 
power than splitting into a single training and test set (Hawkins, 2004).) One view is that an 
ideal splitting leads to a test set such that each of its members is close to at least one member 
of the training set (Tropsha et al., 2003), although it can be argued that this leads to an 
unrealistic test set which overestimates the performance of the model as a predictive tool. 
Approaches for the selection of training and test sets range from the straightforward random 
selection (Yasri and Hartsough, 2001), through activity sampling and various systematic 
clustering techniques (Potter and Matter, 1998; Taylor, 1995), to the methods of self-
organising maps (Gasteiger and Zupan, 1993), Kennard and Stone algorithm (Kennard and 
Stone, 1969), formal statistical experimental design (Eriksson and Johansson, 1996), and the 
modified sphere exclusion algorithm (Golbraikh et al., 2003). However, it is recommended 
that, whenever possible, the external predictivity of the model should be assessed based on a 
test set drawn from the studied general population (domain) of nanoparticles independently 
from sampling the training set nanoparticles. This strategy results in more realistic assessment 
of the external predictive ability of the (Q)SAR model than just a single sampling and then 
splitting the samples into the training and test sets (Esbensen and Geladi, 2010). 
To conclude this section (2.4), the above statistical approaches originally developed 
for ÒclassicÓ QSARs are equally appropriate for nano-QSARs; there is no need to invent 
specific statistical measures of goodness-of-fit, robustness and predictivity. However, the 
typically small size of nano-QSAR datasets means certain considerations related to estimating 
model performance from data resampling are particularly pertinent, as discussed above. 
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2.5. Mechanistic interpretation, if possible 
 
According to the fifth OECD Principle (OECD, 2007), a (Q)SAR should be associated 
with a Òmechanistic interpretationÓ, wherever such an interpretation can be made. The 
purpose of this was to allow for interpretation of QSAR in a manner that would increase 
confidence and reduce the possibility of models based on chance correlations. Obviously, it is 
not always possible to provide a mechanistic interpretation of a given (Q)SAR. The intent of 
this principle is therefore to ensure that there is an assessment of the mechanistic associations 
between the descriptors used in a model, if any, and the endpoint being predicted, and that 
any assessment is documented. Where a mechanistic interpretation is possible, it can also 
form part of the defined applicability domain (section 2.3). 
Consequently, a useful (Q)SAR model may lack mechanistic interpretation because a 
model is in its early stages of evolution, because the mechanistic elements of the application 
domain have not been compiled from the literature, or because the underlying toxicity 
mechanisms are still not fully scientifically understood. Principle 5 encourages the validation 
process to include mechanistic interpretations, which can add to the understanding of the 
statistical validity and the domain of application. 
The mechanistic interpretation of (Q)SARs for nanomaterials represents a major 
challenge because it should be based on (i) an understanding of the mechanism of action 
within an appropriate Adverse Outcome Pathway (AOP) (OECD, 2013b) triggered by the 
nanomaterial at different stages of systemic transport, (ii) knowledge of the Molecular 
Initiating Events (MIE) for the AOP, and once (i) and (ii) are known, (iii) quantitative 
understanding of interactions at the nano-bio interface. This possibility depends on the 
availability of the relevant nanomaterialsÕ structural characteristics, from physicochemical 
characterisation, and mechanistic information. 
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We should state that the majority of interactions at the nano-bio interface cannot be 
currently understood and interpreted (quantitatively) due to the lack of adequate molecular 
models (Boulos et al., 2013). Therefore, the mechanistic interpretations of pathways leading 
to e.g. genotoxicity, protein misfolding (Khan et al., 2013), and promotion of protein 
aggregation (e.g. amyloid fibre formation) cannot be directly made (but may be assumed in 
certain cases). In contrast, the pathways involving more basic interactions leading to oxidative 
stress, inflammation, due to ion release of dissociating ions etc. can be directly assessed 
(Fahmy and Cormier, 2009; Manke et al., 2013; Xia et al., 2008; Yang et al., 2009). However, 
it remains the case that full understanding of the biological significance of key nanomaterial 
properties, such as particle shape, has still not been achieved (Bai et al., 2017). 
In summary, the evolving state of understanding regarding the mechanistic basis of 
nanomaterial toxicity means that it is understandable if the mechanistic basis for nano-QSAR 
models is somewhat speculative. On the other hand, nano-QSAR studies may themselves help 
to advance mechanistic understanding (Bai et al., 2017; Gajewicz et al., 2015). 
 
3. Applying the OECD principles to nano-QSAR models: examples from the NanoSafety 
Modelling Cluster 
 
In order to illustrate how the OECD principles may be applied, in keeping with the 
detailed discussion presented in section 2, to nano-QSAR models, we critically evaluated four 
examples taken from the literature. Specifically, these models were developed with the 
support of projects in the NanoSafety Modelling Cluster, as defined in the Introduction, 
sometimes in collaboration with external researchers and initiatives. The models are listed in 
Table 1 and the evaluations are presented in Table 2.  
Importantly, in keeping with Burello (Burello, 2017), we do not apply a simplistic, 
tick box Òreject vs. acceptÓ approach to evaluation according to the five principles. Rather, we 
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advocate that careful evaluation of nano-QSAR models be performed by experts in QSAR 
modelling of nanomaterials in consultation with experts in the relevant area of experimental 
nanoscience and the intended application area (e.g. regulatory decision making), as applicable.  
For brevity, we do not raise every single possible question which experts in these areas 
would need to pose. Rather, the key questions posed in Table 2 reflect important 
considerations building upon our discussion under section 2. Other relevant questions, which 
would require more detailed critical examination of the models, should also be considered. 
For example, additional aspects related to data quality and completeness, e.g. in terms of the 
physicochemical characterization and experimental metadata, would be relevant for assessing 
compliance with principles 1 (a defined endpoint, discussed in section 2.1) and 3 (a defined 
domain of applicability, discussed in section 2.3). A detailed discussion of assessing the 
completeness and quality of nanomaterial data was recently presented elsewhere (Marchese 
Robinson et al., 2016). In addition to descriptive documentation of the modelling workflow, 
full compliance with principle 2 (discussed in section 2.2), may require the relevant source 
code and, where relevant, random number generator seeds and other computational details to 
be documented in order to fully reproduce the models, and/or for the structure of the models 
to be encoded in the Predictive Model Markup Language (PMML) along with other necessary 
information required to calculate the descriptors etc. (Editorial, 2014; Helma et al., 2017; 
Tetko et al., 2017). (The Òother necessary informationÓ might be documented using the 
QMRF or QSARdb formats (Tetko et al., 2017), possibly with adaptations as discussed in 
section 2.2.)   Likewise, careful consideration is required of whether the performance statistics 
were suitable (Alexander et al., 2015) and were obtained from reliable, truly external, or 
otherwise unbiased, validation protocols, as is discussed in section 2.4 and in key literature 
references (Braga-Neto and Dougherty, 2004; Hawkins, 2004; Hawkins et al., 2003; Tropsha, 
2010; Tropsha et al., 2003). A relevant consideration, regarding the reliability of the 
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validation statistics, relates to the size of the nanomaterial datasets, which are typically small, 
as discussed under section 2.4. Regarding the principle of a mechanistic interpretation, as 
discussed in section 2.5, the fact that our understanding of the mechanisms of action of 
nanomaterial effects may be expected to continue to evolve, means that assessing the 
mechanistic plausibility of a nano-QSAR model remains challenging. Finally, regarding the 
question of whether the endpoint is relevant for the intended application of the model, as 
discussed in section 2.1, the evaluated models (Table 1) might be considered for use in a 
variety of different contexts (e.g. initial screening or safety-by-design by manufacturers, as 
compared to decision support for regulators) and, outside of a specific context, this question 
cannot be directly answered.  
 
Table 1. Summary of models evaluated in Table 2 
Model Label Model Title and Reference Supporting Project(s) 
Model 1 Random Forest nanosilica cytotoxicity model  
(Cassano et al., 2016) 
NanoPUZZLES 
Model 2 SVM metal oxide nanoparticle toxicity classifier  
(Liu et al., 2013a) 
MODERN 
Model 3 CORAL carbon nanotube mutagenicity model  
(Toropov and Toropova, 2015)  
PreNanoTox & NanoPUZZLES 
Model 4 Local weighted Random Forest (proteomics descriptors) gold 
and silver nanoparticle cell association model  
(Helma et al., 2017)  
eNanoMapper 
 
 
Table 2. Minimal evaluation of selected nano-QSAR models (Table 1) according to the OECD principles 
OECD 
Principle 
Key Question Model 1 
 
Model 2 
 
Model 3 
 
Model 4 
 
A defined 
endpoint 
(section 2.1) 
Is a precise 
definition of the 
endpoint 
provided (e.g. an 
ontology 
definition)? 
Yes. The endpoint 
is –log(EC25), fully 
described, for the 
in vitro WST-1 
assay. 
The definition of 
“toxic” vs. “non-
toxic” classes is 
clearly described. 
However, as this is 
based upon 
clustering analysis 
of data from a 
variety of toxicity 
assays, the 
interpretation of this 
endpoint is arguably 
complicated.  
Yes. The endpoint 
is defined as –
log(TA100), where 
TA100 is defined 
as the mean 
mutant counts 
from the 
Salmonella 
microsome test in 
the TA100 strain 
tested at one, out 
of many, doses. 
Yes. The endpoint is 
log2[net cell 
association],  where 
net cell association 
was described 
herein (Helma et al., 
2017) and precisely 
defined in the cited 
original data source 
(Walkey et al., 
2014). 
Are the test 
methods / 
assays, along 
with the key 
Yes, to some 
extent. The assay, 
cell type and 
treatment type are 
Yes Yes Yes, in the original 
source of the 
dataset (Walkey et 
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experimental 
variables, used 
to generate the 
endpoint data 
documented? 
documented. Other 
relevant details, 
e.g. exposure 
medium details, 
are not provided. 
al., 2014). 
Are the data 
“reasonably” 
experimentally 
consistent? 
Data were 
combined from 
diverse protocols, 
e.g. different cell 
types. However, 
this variability is 
accounted for via 
considering the 
varied 
experimental 
conditions as 
descriptors. 
Whilst data from 
multiple assays 
were combined to 
provide the “toxic” 
vs. “non-toxic” 
endpoint, each 
individual assay 
was performed 
according to a 
consistent protocol 
as described in a 
single primary 
literature citation 
(Zhang et al., 2012). 
Data were 
generated 
according to 
different 
conditions, yet in 
the same lab 
according to a 
single 
experimental 
protocol described 
in the cited 
primary literature 
reference 
(Wirnitzer et al., 
2009). However, 
this variability is 
accounted for via 
considering the 
varied 
experimental 
conditions as 
descriptors.  
Data were 
generated according 
to a single 
experimental 
protocol  (Walkey et 
al., 2014). 
Are units 
provided for 
numerical 
endpoints? 
Yes. The units for 
the EC25 values 
are provided. 
N/A N/A  Yes 
Have 
concentration / 
dose related 
units been 
converted from 
mass based 
units (e.g. into 
surface area 
based units)? 
Yes. The EC25 
values are 
expressed in 
surface area 
concentration 
units. 
No (Zhang et al., 
2012) 
No (Wirnitzer et 
al., 2009) 
No  
Has the potential 
for nanomaterial 
interference with 
the assays been 
excluded? 
This is unclear. It 
has been 
suggested that the 
WST-1 assay 
avoids certain 
interference 
problems with 
some carbon 
based 
nanomaterials, 
compared to some 
other cytotoxicity 
assays (Domey et 
al., 2013). 
This is unclear. This is unclear. This is unclear. 
Has endotoxin 
or residual 
solvent 
contamination 
been assessed? 
This was not 
addressed. 
This was not 
addressed. 
This was not 
addressed. 
This was not 
addressed. 
An 
unambiguous 
algorithm 
(section 2.2) 
Which 
descriptors were 
used? 
An expert selected 
combination of 
physicochemical 
measurement and 
experimental 
variables, all 
converted to binary 
variables, were 
A pool of thirty 
descriptors was 
initially considered, 
including simple 
atom counts, 
experimental 
properties of the 
constituents, and 
Different 
experimental 
conditions were 
converted to 
labels 
incorporated into 
“quasi-SMILES”. 
Experimental 
measurements 
characterizing 
interactions with 
proteins in human 
serum, as fully 
described in the 
original source of 
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used.  conduction band 
energy estimated 
from the measured 
band gap (Zhang et 
al., 2012). This 
initial pool of 
descriptors was 
reduced to two via 
statistical feature 
selection: the 
conduction band 
energy and the ionic 
index of the metal 
cation. 
the dataset (Walkey 
et al., 2014), were 
reduced via feature 
selection. 
Which statistical 
/ machine 
learning 
algorithm was 
used? 
Random Forest SVM The CORAL 
software was 
employed 
(http://www.insilico
.eu/coral). 
Weighted local 
average Random 
Forest modelling, 
trained on the 
nearest neighbours 
identified via 
descriptor similarity. 
A defined 
domain of 
applicability 
(section 2.3) 
Have the 
modelled 
nanomaterials 
been adequately 
characterized in 
terms of their 
physico-
chemical 
characteristics? 
To some extent. 
The composition of 
the core and, to 
some extent, 
details of the 
coatings are 
provided in the 
Supporting 
Information. Some 
additional 
physicochemical 
characterization 
data are provided, 
with partial 
description of 
experimental 
protocols.  
To a considerable 
extent. The 
chemical 
composition, along 
with experimentally 
measured sizes, 
zeta potential, 
dissolution profile 
and crystalline 
structure are 
provided, along with 
experimental 
details, in the cited 
primary literature 
(Zhang et al., 2012).  
To some extent. 
The tested 
nanomaterials 
were described as 
the commercially 
available 
Baytubes® (multi-
walled carbon 
nanotubes) and a 
characterization of 
size and shape 
distribution for the 
prepared samples 
is provided in the 
primary literature 
reference 
(Wirnitzer et al., 
2009). N.B. Since 
only experimental 
conditions were 
incorporated into 
the model, based 
on results for a 
single 
nanomaterial, it 
could not be 
expected to be 
applicable to 
anything other 
than these same 
nanomaterials.  
To a considerable 
extent. Detailed 
descriptions of core 
and surface 
chemical 
composition are 
provided, alongside 
detailed 
measurement of 
size distributions, 
according to a 
variety of 
techniques, and zeta 
potential in the 
original source of 
the dataset (Walkey 
et al., 2014). 
Has an 
applicability 
domain been 
defined? 
No Yes Yes, based on 
analysis of the 
“quasi-SMILES”. 
Yes 
Are uncertainty 
estimates 
provided for 
predictions? 
No In some sense: the 
model estimates the 
probability of being 
toxic. 
No Yes (95% prediction 
intervals) 
Appropriate 
measures of 
goodness-of-
fit, robustness 
and 
predictivity 
(section 2.4) 
How was the 
ability of the 
model to make 
predictions for 
untested 
nanomaterials 
assessed?  
“External” LOO 
cross-validation 
Via the “0.632 
estimator”, based 
on bootstrapping. 
LMO cross-
validation 
5 repetitions of 10-
fold cross-validation, 
with feature 
selection being 
repeated for each 
training set to avoid 
overfitting 
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What were the 
overall 
performance 
statistics and 
their values? 
R
2
 = 0.78 Balanced 
classification 
accuracy = 93.74% 
r
2
 (correlation 
coefficient)
 
= 0.74 
– 0.80 (across 
three validation 
splits); 0.75 – 0.82 
(only considering 
instances inside 
the domain of 
applicability) 
r
2
 (explained model 
variance) = 0.55 – 
0.68 across all five 
repetitions of cross-
validation; RMSE = 
1.51 – 1.8 log units; 
87 – 92% of 
predictions within 
the 95% prediction 
intervals  
Mechanistic 
interpretation, 
if possible 
(section 2.5) 
Was a 
mechanistic 
interpretation 
proposed by the 
study authors? 
This issue is 
touched upon, but 
a full mechanistic 
interpretation is not 
provided. 
Yes Yes No 
How do the 
study authors 
arrive at this 
interpretation? 
They evaluate 
“feature 
contributions” for 
Random Forest. 
They evaluate the 
range of descriptor 
values associated 
with toxic vs. non-
toxic classifications, 
according to the 
model. 
They consider 
variables which 
have a “stable 
positive correlation 
weight” with the 
endpoint. 
N/A 
Do the study 
authors consider 
whether this 
mechanistic 
interpretation is 
consistent with 
current 
understanding? 
Yes   Yes No N/A 
 
 
4. Conclusions 
 
(Quantitative) Structure-Activity Relationship ([Q]SAR) modelling is one possibility 
for estimating hazard or exposure related characteristics, either in the context of a risk 
assessment or as part of a Òsafe-by-designÓ approach. It might be used for predicting a variety 
of properties, including toxicity of newly designed nanoparticles. However, every nano-
(Q)SAR must be appropriately validated, which is crucial for ensuring its predictive accuracy. 
In this contribution, we proposed an interpretation of the well-known ÒOECD Principles for 
the Validation, for Regulatory Purposes, of (Q)SAR ModelsÓ in the context of nano-(Q)SAR 
and presented our opinion on the criteria to be fulfilled by every model developed for 
nanoparticles, whether employed in a regulatory context or otherwise. 
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In general, we agree that the OECD principles create an appropriate framework for 
validating nano-(Q)SARs as well. However, special attention is required for some issues 
specific to nanoparticles. The most important conclusions are as follows: 
¥ Careful consideration is required as to whether or not the activity data are reliable, due 
to various potential pitfalls associated with experimental assessment of nanomaterial 
activity, and whether or not appropriate concentration/dose units have been used. 
¥ Classic molecular descriptors are typically, but not always, inappropriate for 
modelling nanoparticles. On the other hand, newly developed descriptors should be 
validated and reported by providing the details necessary for anyone interested to 
calculate them or, where applicable, obtain them from experimental characterization 
of the nanomaterials. 
¥ It is highly recommended that the models are presented and documented in a format 
such as the descriptive (Q)SAR Model Reporting Format (QMRF), or the machine 
readable QsarDB format Ð including model representation using Predictive Model 
Markup Language (PMML) and, whenever possible, be placed in public repositories 
and exposed as web applications to ensure their transparency and reproducibility. N.B. 
Guidance on suitable linked data files, or possibly other adaptations of these formats, 
is required to ensure their suitability for nano-QSAR, as opposed to classical (Q)SAR, 
models.  
¥ Compared to classical (Q)SAR modelling, it seems much more important to achieve a 
balance between the level of confidence in the predictions of a nano-(Q)SAR and its 
scope (i.e., applicability domain). It is essential to reach a balance between ÒlocalÓ and 
ÒglobalÓ models. 
¥ Nano-bio interactions involving nanoparticles are not fully determined by the particle 
chemistry alone. Because of that, mechanistic interpretation of nano-(Q)SARs can be 
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more problematic than those for classic (Q)SAR models; very often a wider context is 
required.  
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